From July 22 to 24, 2025, we took part in the 6th edition of the Central European Biomedical Congress (CEBC) – an event dedicated to the applications of neuropharmacology, bioinformatics, and artificial intelligence in medicine.
This year’s congress was held in Kraków under the theme “Integrating Neuropharmacology and Bioinformatics with AI.” It brought together experts from all over Europe to share knowledge, present research findings, and jointly discuss the future of diagnostics and therapy in neurological disorders. It was an inspiring space for idea exchange and international collaboration – and we were proud to be there as Pure Clinical.
Three days of dialogue, inspiration, and forward-looking perspectives
Throughout the congress, we took part in numerous expert discussions and networking sessions – covering topics from regulatory strategies to the use of AI tools in clinical neurology. The diversity of perspectives and the readiness for genuine cooperation made CEBC an extremely valuable event for us.
Not only innovative, but also applicable
— “CEBC is a reminder of how rapidly the landscape of biomedical science is evolving and how important it is to connect competencies – from pharmacology to AI and data analysis,” says Fryderyk Janiak, Business Development Manager at Pure Clinical. He adds: “In discussions with experts from different countries, one common need emerged clearly: better integration of innovative technologies into clinical realities. For us, this is a clear signal that the future of diagnostics and therapy must be not only modern, but also truly applicable.”
Thank you for being there – let’s stay in touch!
We’re grateful for all the inspiring conversations and new connections. Once again, CEBC proved the vital role of interdisciplinary and international collaboration in the MedTech field. See you at the next edition!
